Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-04-20FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
The FDA approved Purdue Pharma LP's supplemental application for OXYCONTIN (oxycodone hydrochloride), updating labeling as part of the suppl…
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for methadone hydrochloride by VistaPharm, LLC, representing an approved change to an already-ap…
-
FDA approval · 2016-04-20FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)
FDA approved a supplemental application for Morphine Sulfate Extended Release submitted by Rhodes Pharmaceuticals L.P.
-
FDA approval · 2016-04-20FDA Approved: MORPHINE SULFATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA granted approval for a supplemental application for Morphine Sulfate, submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved Aurolife Pharma's supplemental application for methadone hydrochloride, granting approval of a generic methadone hydrochloride …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for Methadone hydrochloride by Epic Pharma, LLC.
-
FDA approval · 2016-04-20FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)
FDA approved a supplemental application for Belbuca (buprenorphine hydrochloride buccal film) to support its labeling for the treatment of c…
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application for methadone hydrochloride manufactured by SpecGx LLC.
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Methadone Hydrochloride from Hikma Pharmaceuticals USA Inc., updating an existing generic produc…
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc. The approval covers labeling and…
-
FDA approval · 2016-04-20FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for FENTANYL TRANSDERMAL by SpecGx LLC, a generic fentanyl transdermal patch.
-
FDA approval · 2016-04-20FDA Approved: MORPHINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Morphine Sulfate from Sun Pharmaceutical Industries, Inc., indicating regulatory approval of a c…
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients
This update describes a completed pilot functional imaging study investigating the mechanisms of chronic pain in patients with breast cancer…
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: Simultaneously Targeting Obesity and Pain: The STOP Trial [NA]
An update on the STOP trial, a study intended to simultaneously target obesity and chronic pain; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block [NA]
Clinical trial completed evaluating intravenous dexamethasone to extend analgesic duration of interscalene nerve block for pain relief.
-
FDA approval · 2016-04-12FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved a generic version of hydrocodone bitartrate and acetaminophen for pain relief, under an Original Application by Rhodes Pharmace…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
This completed clinical trial investigated risk factors and pathophysiological mechanisms for persistent pain after breast cancer treatment.
-
FDA approval · 2016-03-31FDA Approved: OXYCODONE HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic oxycodone hydrochloride product under an original ANDA, adding a generic option for managing a…
-
CLINICAL_TRIALS research · 2016-03-30Clinical Trial Update: Observational Study Linking Genetic Variants With Clinical Outcomes in Pain Management
An observational study sponsored by Proove Bioscience examining associations between genetic variants and clinical outcomes in chronic pain …
-
CLINICAL_TRIALS research · 2016-03-30Clinical Trial Update: A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care [NA]
This document provides an update on a clinical trial examining how genetic testing influences clinical decision making and patient care, spo…
-
FDA approval · 2016-03-28FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for OxyContin (oxycodone hydrochloride) from Purdue Pharma LP. The approval authorizes changes outli…
-
FDA approval · 2016-03-16FDA Approved: CELECOXIB — Original Application (McKesson Corporation dba SKY Packaging)
FDA approved the original Abbreviated New Drug Application for a generic celecoxib product manufactured by McKesson Corporation dba SKY Pack…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy [NA]
This clinical trial update reports completed results for the Bioness StimRouter neuromodulation system in chronic pain. The results have bee…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents [NA]
A completed UCLA-sponsored clinical trial evaluated peer mentorship as an intervention to promote effective pain self-management in adolesce…
-
FDA approval · 2016-03-08FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Alvogen, Inc.)
The FDA approved a supplemental application for the generic oxycodone and acetaminophen from Alvogen, Inc., confirming regulatory approval r…